CTVA vs FCX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Corteva (CTVA) trades at a premium valuation with mixed profitability trends and strong recent earnings surprises, though near-term earnings growth remains challenged. The stock has underperformed over the past six months (-3.3%) despite solid 1-year and 5-year returns (+16.1%, +85.9%), reflecting macro pressures in agricultural inputs. While revenue growth of 12.6% outpaces the sector average of 6.16%, negative operating margins (-10.31%) and volatile quarterly EPS performance raise concerns about execution and cost structure. Analysts are constructive with a $77.71 target implying 17.7% upside, but recent insider selling adds caution, offsetting an otherwise healthy balance sheet and sustainable dividend policy.
FCX shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
CTVA vs FCX: Head-to-Head Comparison
This page compares Corteva, Inc. (CTVA) and Freeport-McMoRan Inc. (FCX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.